Healthcare -
Biotechnology - NASDAQ - US
$ 8.35
1.09 %
$ 81.2 M
Market Cap
-0.23
P/E
BLUE - COST OF REVENUE
Cost of Revenue BLUE - bluebird bio, Inc.
33.5 M
LAST VALUE
-7.11%
2 YEAR CAGR
106.87%
5 YEAR CAGR
0.79%
10 YEAR CAGR